Recombinant TAG-72 (Minretumomab Biosimilar) anticorps

N° du produit ABIN7795096

Cet anticorps anti-TAG-72 (Minretumomab Biosimilar) est un anticorps Humanized Monoclonal détectant TAG-72 (Minretumomab Biosimilar) dans FACS et in vivo. Adapté pour Humain.

Aperçu rapide pour Recombinant TAG-72 (Minretumomab Biosimilar) anticorps (ABIN7795096)

Antigène: TAG-72 (Minretumomab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp TAG-72 (Minretumomab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-TAG-72 (Minretumomab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Minretumomab Biosimilar, TAG-72 Monoclonal Antibody

Attributs du produit: Minretumomab Biosimilar uses the same protein sequences as the therapeutic antibody minretumomab. Minretumomab is a mouse monoclonal antibody that was designed for the treatment of cancers that express the TAG-72 antigen. This includes breast, colon, lung, and pancreatic cancers. A wide range of derivatives has been used in pharmaceutical research. Examples include chimeric and humanized minretumomab, as well as a fusion protein of a minretumomab single-chain variable fragment and the enzyme beta-lactamase.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Immunogène: Human TAG-72

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur TAG-72 (Minretumomab Biosimilar)

Antigène: TAG-72 (Minretumomab Biosimilar)

Autre désignation: Minretumomab Biosimilar

Classe de substances: Biosimilar